Advances in the treatment of systemic lupus erythematosus: Biologicals, small‐molecular agents, and cell‐depleting therapies coming to the clinic

Journal of Internal Medicine · Published 2026-08-05 · DOI 10.1111/joim.70146

Free full text

Authors (1)

Ronald van Vollenhoven

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Vollenhoven, R. (2026). Advances in the treatment of systemic lupus erythematosus: Biologicals, small‐molecular agents, and cell‐depleting therapies coming to the clinic. Journal of Internal Medicine. https://doi.org/10.1111/joim.70146

Related articles

• Old and new autoantibodies in systemic lupus erythematosus · Expert Review of Clinical Immunology · 2026 · Cites or is cited by this article
• Induction treatment of lupus nephritis: to pulse or not to pulse? Whether ’tis nobler to universally or selectively prescribe · Lupus Science and Medicine · 2025 · Cites or is cited by this article
• Low-dose IL-2 therapy in autoimmune diseases: An update review · International Reviews of Immunology · 2023 · Cites or is cited by this article
• Acute clinical events and trajectories of frailty after age 60: A population‐based cohort study · Journal of Internal Medicine · 2026 · Same journal
• Blood biomarkers of Alzheimer's disease and 15‐year decline in cognitive and motor functions in older adults · Journal of Internal Medicine · 2026 · Same journal
• Anti‐inflammatory agents in atherosclerosis—and a need for reform: Extraordinary claims require extraordinary evidence · Journal of Internal Medicine · 2026 · Same journal
• Perioperative immune checkpoint inhibitor therapy across tumors: Insights and shared lessons from a rapidly evolving field · Journal of Internal Medicine · 2026 · Same journal
• Fecal microbiota transplantation‐based treatment protocol for chronic insomnia disorder: A randomized, double‐blind, placebo‐controlled trial · Journal of Internal Medicine · 2026 · Same journal
• Epigenetic analyses suggest different pathways during pregnancy for development of type 1 diabetes in children with high versus low‐neutral human leukocyte antigen‐risk · Journal of Internal Medicine · 2026 · Same journal
• Collagen and microvascular alterations contribute to neuromuscular degeneration and disease progression in chronic intestinal pseudo‐obstruction · Journal of Internal Medicine · 2026 · Same journal